Gyre Therapeutics, Inc. (GYRE)

NCM – Real Time Price. Currency in USD

6.80

+0.16 (2.38%)

Market open: Aug 12, 2026, 10:14 AM EDT

6.65

+0.01 (0.15%)

Previous after-hours: Aug 11, 2026, 4:30 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

117M

106M

113M

102M

Cost of goods sold

-5M

-4M

-5M

Gross Profit

111M

102M

109M

97M

Operating expenses (excl. COGS)

-100M

-86M

-90M

-88M

Operating Income

11M

16M

19M

Non-operating income, total

-96M

209K

Pretax income

14M

23M

-77M

Equity in earnings

Taxes

-5M

-9M

-5M

Non-controlling/minority interest

-5M

-6M

-7M

-2M

After tax other income/expense

Net income before discontinued operations

12M

-93M

Discontinued operations

Net income

12M

-93M

Dilution adjustment

-3M

-7M

Preferred dividends

Gyre Therapeutics, Inc. (GYRE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Gyre Therapeutics, Inc. (GYRE)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Gyre Therapeutics, Inc. (GYRE)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Gyre Therapeutics, Inc. (GYRE)

Income Statement (Annual)

Income Statement (Annual)